<DOC>
	<DOCNO>NCT01753297</DOCNO>
	<brief_summary>The purpose study assess benefit immediate hormonal treatment Radical Prostatectomy Chinese Russian patient high risk prostate cancer . To reach target , trial compare group patient treat triptorelin 8 week surgery duration 9 month ( 3 injection ) versus another group ( call `` active surveillance group '' ) receive triptorelin . Both group follow every 3 month monitor sign disease progression minimum 36 month</brief_summary>
	<brief_title>A Study Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy High Risk Prostate Cancer Patients .</brief_title>
	<detailed_description>This trial phase IV ( Russia China ) approve indication locally advance metastatic prostate cancer country .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>Histopathologically confirm adenocarcinoma prostate Radical Prostatectomy curative intent perform 8 week randomisation High risk criterion disease progression , define follow : Gleason score ≥8 prostatectomy specimen , and/or Pre RP PSA level ≥20 ng/mL , and/or Primary tumour stage 3a ( pT3a ) ( PSA level Gleason score ) PostRP PSA level ≤0.2 ng/mL 6 week Evidence lymph node distant metastasis Positive margin Evidence malignant disease , treat curative intent Had surgical castration</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>